Back to results
US 5,292,668 AGranted
Bispecific antibody determinants
AssigneeBoston Biomedical Research Institute
InventorHenry P. Paulus
Life of this patent
Estimating the term…
Abstract
A homogenous sample of identical bispecific antibody determinants, each determinant being composed of two L-H half-molecules linked by disulfide bonds, each L-H half-molecule being specific for a different antigenic determinant and including at least the F(ab') portion of a monoclonal IgG antibody. The bispecific antibody determinants are useful, e.g., in the formation of multilamellar assemblies and in enzymatic assays.
Claims1
A process for preparing covalent hybrid antibodies comprising the steps of:
- A) selectively cleaving a first monoclonal immunoglobulin molecule which is an antibody to a first antigen into its heavy chain-light chain half-molecules by cleavage of the inter-heavy chain disulfide linkage to produce half-molecules;
- B) selectively cleaving a second monoclonal immunoglobulin molecule which is an antibody to the first or a second antigen into its heavy chain-light chain half-molecules by reduction of the inter-heavy chain disulfide linkage to produce reduced half-molecules;
- and
- C) combining the half-molecules from step (A) with the reduced half-mulecules from step (B).
1 more element
Dependencies are inferred from the claim text.